Eliem Therapeutics: Funding, Investors & Team (Oct 2026)
Eliem Therapeutics is a biotechnology company that is in the clinical stage of development and focuses on creating treatments for disorders of the nervous system. The company utilizes its knowledge in neuroscience, translational medicine, and clinical development to address the medical need in this area with an innovative pipeline. Eliem Therapeutics works on developing and bringing to market drug candidates that could potentially be the best in their class for treating disorders related to neuronal excitability. These disorders, including chronic pain, depression, epilepsy, and anxiety, significantly impact the lives of millions of individuals daily. The primary motivation of the Eliem team is to provide patients with the opportunity to lead happier and more fulfilling lives.
Eliem Therapeutics has raised $180M across 2 funding rounds on record, the most recent an undisclosed round of $120M announced in Apr 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Eliem Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2024.
Eliem Therapeutics Funding Rounds
Eliem Therapeutics raised $60.0M in an undisclosed round announced in May 2021.
2.9 years later, an undisclosed round of $120M was announced in Apr 2024.
Eliem Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Eliem Therapeutics Funding Compared to Other Biotechnology Startups
Eliem Therapeutics' latest round of $120M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Eliem Therapeutics in Biotechnology and Redmond
Companies Similar to Eliem Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Eliem Therapeutics Funding FAQs
What does Eliem Therapeutics do?
Eliem Therapeutics is a biotechnology company that is in the clinical stage of development and focuses on creating treatments for disorders of the nervous system. The company utilizes its knowledge in neuroscience, translational medicine, and clinical development to address the medical need in this area with an innovative pipeline. Eliem Therapeutics works on developing and bringing to market drug candidates that could potentially be the best in their class for treating disorders related to neuronal excitability. These disorders, including chronic pain, depression, epilepsy, and anxiety, significantly impact the lives of millions of individuals daily. The primary motivation of the Eliem team is to provide patients with the opportunity to lead happier and more fulfilling lives.
How much funding has Eliem Therapeutics raised?
Eliem Therapeutics has raised $180M across 2 rounds on record. The most recent is an undisclosed round of $120M announced in Apr 2024.
When did Eliem Therapeutics last raise funding?
Eliem Therapeutics' most recent funding round on record is an undisclosed round of $120M, announced in Apr 2024.
Who founded Eliem Therapeutics?
FundedIQ lists Valerie Morisset (Founder) at Eliem Therapeutics.
Who is the CEO of Eliem Therapeutics?
Bob Azelby is listed as CEO at Eliem Therapeutics.
Where is Eliem Therapeutics headquartered?
Eliem Therapeutics is based in Redmond, Washington, United States.
How many employees does Eliem Therapeutics have?
Eliem Therapeutics is in the 11-50 employee band.
How does Eliem Therapeutics' funding compare to other Biotechnology startups?
Eliem Therapeutics' latest round of $120M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Eliem Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Eliem Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.